Match!

The Clinical Potential of Senolytic Drugs

Published on Oct 1, 2017in Journal of the American Geriatrics Society4.113
· DOI :10.1111/jgs.14969
James L. Kirkland59
Estimated H-index: 59
(Mayo Clinic),
Tamara Tchkonia45
Estimated H-index: 45
(Mayo Clinic)
+ 2 AuthorsPaul D. Robbins107
Estimated H-index: 107
(Scripps Research Institute)
Sources
Abstract
Senolytic drugs are agents that selectively induce apoptosis of senescent cells. These cells accumulate in many tissues with aging and at sites of pathology in multiple chronic diseases. In studies in animals, targeting senescent cells using genetic or pharmacological approaches delays, prevents, or alleviates multiple age-related phenotypes, chronic diseases, geriatric syndromes, and loss of physiological resilience. Among the chronic conditions successfully treated by depleting senescent cells in preclinical studies are frailty, cardiac dysfunction, vascular hyporeactivity and calcification, diabetes mellitus, liver steatosis, osteoporosis, vertebral disk degeneration, pulmonary fibrosis, and radiation-induced damage. Senolytic agents are being tested in proof-of-concept clinical trials. To do so, new clinical trial paradigms for testing senolytics and other agents that target fundamental aging mechanisms are being developed, because use of long-term endpoints such as lifespan or healthspan is not feasible. These strategies include testing effects on multimorbidity, accelerated aging-like conditions, diseases with localized accumulation of senescent cells, potentially fatal diseases associated with senescent cell accumulation, age-related loss of physiological resilience, and frailty. If senolytics or other interventions that target fundamental aging processes prove to be effective and safe in clinical trials, they could transform geriatric medicine by enabling prevention or treatment of multiple diseases and functional deficits in parallel, instead of one at a time.
  • References (46)
  • Citations (96)
📖 Papers frequently viewed together
20157.35Aging Cell
33 Authors (Yi-Yi Zhu, ..., James L. Kirkland)
399 Citations
201336.22Cell
3,490 Citations
201643.07Nature
669 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References46
Newest
#1Heike Fuhrmann-Stroissnigg (Scripps Research Institute)H-Index: 9
#2Yuan Yuan Ling (Scripps Research Institute)H-Index: 10
Last. Paul D. Robbins (Scripps Research Institute)H-Index: 107
view all 20 authors...
Aging is the main risk factor for many chronic degenerative diseases and cancer. Increased senescent cell burden in various tissues is a major contributor to aging and age-related diseases. Recently, a new class of drugs termed senolytics were demonstrated to extending healthspan, reducing frailty and improving stem cell function in multiple murine models of aging. To identify novel and more optimal senotherapeutic drugs and combinations, we established a senescence associated β-galactosidase as...
95 CitationsSource
#1Yi Zhu (Mayo Clinic)H-Index: 17
#2Ewald J. Doornebal (UG: University of Groningen)H-Index: 2
Last. James L. Kirkland (Mayo Clinic)H-Index: 59
view all 10 authors...
Senescent cells accumulate with aging and at sites of pathology in multiple chronic diseases. Senolytics are drugs that selectively promote apoptosis of senescent cells by temporarily disabling the pro-survival pathways that enable senescent cells to resist the pro-apoptotic, pro-inflammatory factors that they themselves secrete. Reducing senescent cell burden by genetic approaches or by administering senolytics delays or alleviates multiple age- and disease-related adverse phenotypes in preclin...
76 CitationsSource
#1Marjolein P. Baar (Erasmus University Medical Center)H-Index: 1
#2Renata M. C. Brandt (Erasmus University Medical Center)H-Index: 13
Last. Peter L.J. de Keizer (Buck Institute for Research on Aging)H-Index: 3
view all 21 authors...
The accumulation of irreparable cellular damage restricts healthspan after acute stress or natural aging. Senescent cells are thought to impair tissue function, and their genetic clearance can delay features of aging. Identifying how senescent cells avoid apoptosis allows for the prospective design of anti-senescence compounds to address whether homeostasis can also be restored. Here, we identify FOXO4 as a pivot in senescent cell viability. We designed a FOXO4 peptide that perturbs the FOXO4 in...
262 CitationsSource
#1Marissa J. Schafer (Mayo Clinic)H-Index: 14
#2Thomas A. White (Mayo Clinic)H-Index: 26
Last. Nathan K. LeBrasseur (Mayo Clinic)H-Index: 48
view all 23 authors...
Removal of senescent cells rejuvenates lungs of aged mice. Here the authors show that elimination of senescent cells using either genetic or pharmacological means improves lung function and physical health in a mouse model of idiopathic pulmonary fibrosis (IPF), suggesting potential therapy for treatment of human IPF.
203 CitationsSource
#1Jamie N. Justice (Wake Forest University)H-Index: 10
#2Jordan D. Miller (Mayo Clinic)H-Index: 34
Last. James L. Kirkland (Mayo Clinic)H-Index: 59
view all 8 authors...
Therapies targeted at fundamental processes of aging may hold great promise for enhancing the health of a wide population by delaying or preventing a range of age-related diseases and conditions—a concept dubbed the “geroscience hypothesis.” Early, proof-of-concept clinical trials will be a key step in the translation of therapies emerging from model organism and preclinical studies into clinical practice. This article summarizes the outcomes of an international meeting partly funded through the...
24 CitationsSource
#1James L. Kirkland (Mayo Clinic)H-Index: 59
#2Michael B. Stout (Mayo Clinic)H-Index: 16
Last. Felipe Sierra (NIH: National Institutes of Health)H-Index: 16
view all 3 authors...
: Recently discovered interventions that target fundamental aging mechanisms have been shown to increase life span in mice and other species, and in some cases, these same manipulations have been shown to enhance health span and alleviate multiple age-related diseases and conditions. Aging is generally associated with decreases in resilience, the capacity to respond to or recover from clinically relevant stresses such as surgery, infections, or vascular events. We hypothesize that the age-relate...
19 CitationsSource
#1John C. Newman (UCSF: University of California, San Francisco)H-Index: 21
#2Sofiya Milman (Yeshiva University)H-Index: 1
Last. Nir Barzilai (Yeshiva University)H-Index: 71
view all 7 authors...
Interventions that target fundamental aging processes have the potential to transform human health and health care. A variety of candidate drugs have emerged from basic and translational research that may target aging processes. Some of these drugs are already in clinical use for other purposes, such as metformin and rapamycin. However, designing clinical trials to test interventions that target the aging process poses a unique set of challenges. This paper summarizes the outcomes of an internat...
44 CitationsSource
#1Derek M. Huffman (Yeshiva University)H-Index: 20
#2Jamie N. Justice (CU: University of Colorado Boulder)H-Index: 10
Last. Steven N. Austad (UAB: University of Alabama at Birmingham)H-Index: 54
view all 6 authors...
: Life extension is no longer considered sufficient evidence of delayed aging in research animals. It must also be demonstrated that a broad swathe of health indicators have been extended. During a retreat of the Geroscience Network, a consortium of basic and clinical aging researchers, potential measures of mouse health were considered for their potential as easily standardized, highly informative metrics. Major health domains considered were neuromuscular, cognitive, cardiovascular, metabolic,...
15 CitationsSource
#1Christin E. Burd (OSU: Ohio State University)H-Index: 15
#2Matthew S. Gill (Scripps Research Institute)H-Index: 25
Last. James L. Kirkland (Mayo Clinic)H-Index: 59
view all 7 authors...
: Through the progress of basic science research, fundamental mechanisms that contribute to age-related decline are being described with increasing depth and detail. Although these efforts have identified new drug targets and compounds that extend life span in model organisms, clinical trials of therapeutics that target aging processes remain scarce. Progress in aging research is hindered by barriers associated with the translation of basic science discoveries into the clinic. This report summar...
9 CitationsSource
#1Bennett G. Childs (Mayo Clinic)H-Index: 8
#2Darren J. Baker (Mayo Clinic)H-Index: 33
Last. J. M. Van Deursen (Mayo Clinic)H-Index: 72
view all 6 authors...
Cells enter a state of senescence in response to certain stresses. Studying mouse models, Childs et al. examined the role of senescent lipid-loaded macrophages (so-called “foam cells”) in the pathogenesis of atherosclerosis. At early stages of atherosclerosis, senescent foam cells promoted the expression of inflammatory cytokines. At later stages, they promoted the expression of matrix metalloproteases implicated in the rupture of atherosclerotic plaque, which can lead to blood clots. Experiment...
197 CitationsSource
Cited By96
Newest
#1Irene Galiana (Polytechnic University of Valencia)H-Index: 5
#2Beatriz Lozano-Torres (Polytechnic University of Valencia)H-Index: 6
Last. Mar Orzáez (Polytechnic University of Valencia)H-Index: 3
view all 9 authors...
Abstract The induction of senescence produces a stable cell cycle arrest in cancer cells, thereby inhibiting tumor growth; however, the incomplete immune cell-mediated clearance of senescent cells may favor tumor relapse, limiting the long-term anti-tumorigenic effect of such drugs. A combination of senescence induction and the elimination of senescent cells may, therefore, represent an efficient means to inhibit tumor relapse. In this study, we explored the antitumor efficacy of a combinatory s...
Source
#1Jan Martel (Memorial Hospital of South Bend)H-Index: 8
#2David Marcelo Ojcius (Memorial Hospital of South Bend)
Last. John Ding-E YoungH-Index: 47
view all 8 authors...
Senescence is a state of cell cycle arrest that plays an important role in embryogenesis, wound healing and protection against cancer. Senescent cells also accumulate during aging and contribute to the development of age-related disorders and chronic diseases, such as atherosclerosis, type 2 diabetes, osteoarthritis, idiopathic pulmonary fibrosis, and liver disease. Molecules that induce apoptosis of senescent cells, such as dasatinib, quercetin, and fisetin, produce health benefits and extend l...
Source
#1Masum Rahman (Mayo Clinic)
#2Ian Olson (Mayo Clinic)
Last. Mark A. Schroeder (Mayo Clinic)H-Index: 34
view all 21 authors...
Despite decades of research and numerous basic science advances, there have only marginal gains in improving glioblastoma multiforme survival. Therefore, new ideas and approaches for treating this aggressive disease are essential to drive progress forward. Conventional therapies, such as radiation and Temozolomide (TMZ), function to cause oxidative stress and DNA damage yielding a senescent-like state of replicative arrest in susceptible cells. However, increasing evidence demonstrates malignant...
Source
Abstract Much of the population is now faced with an enormous burden of age-associated chronic diseases. Recent discoveries in geroscience indicate that healthspan in model organisms such as mice can be manipulated by targeting cellular senescence, a hallmark mechanism of aging, defined as an irreversible proliferative arrest that occurs when cells experience oncogenic or other diverse forms of damage. Senescent cells and their pro-inflammatory secretome have emerged as contributors to age-relat...
Source
#1Robert J. Pignolo (Mayo Clinic)H-Index: 33
#2Karl A. Nath (Mayo Clinic)H-Index: 68
Source
#1Georgina M. Ellison-Hughes ('KCL': King's College London)H-Index: 7
2 CitationsSource
#1Tamas Fulop (Université de Sherbrooke)H-Index: 55
#2Usma Munawara (Université de Sherbrooke)
Last. Annelise E. Barron (Stanford University)H-Index: 47
view all 16 authors...
Alzheimer's disease (AD) is the most prevalent dementia in the world. Its cause(s) are presently largely unknown. The most common explanation for AD, now, is the amyloid cascade hypothesis, which states that the cause of AD is senile plaque formation by the amyloid β peptide, and the formation of neurofibrillary tangles by hyperphosphorylated tau. A second, burgeoning theory by which to explain AD is based on the infection hypothesis. Much experimental and epidemiological data support the involv...
Source
#1Carey E. Lyons (UMN: University of Minnesota)H-Index: 1
#2Alessandro Bartolomucci (UMN: University of Minnesota)H-Index: 31
Abstract Chronic stress has been shown to promote numerous aging-related diseases, and to accelerate the aging process itself. Of particular interest is the impact of stress on Alzheimer’s Disease (AD), the most prevalent form of dementia. The vast majority of AD cases have no known genetic cause, making it vital to identify the environmental factors involved in the onset and progression of the disease. Age is the greatest risk factor for AD, and measures of biological aging such as shorter telo...
Source
#1Chaska C. Walton (Buck Institute for Research on Aging)H-Index: 1
#2David Begelman (Buck Institute for Research on Aging)H-Index: 1
Last. Julie K. Andersen (Buck Institute for Research on Aging)H-Index: 50
view all 4 authors...
Abstract: Due to their postmitotic status, the potential for neurons to undergo senescence has historically received little attention. This lack of attention has extended to some non-postmitotic cells as well. Recently, the study of senescence within the central nervous system (CNS) has begun to emerge as a new etiological framework for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). The presence of senescent cells is known to be deleterious to non-senes...
1 CitationsSource
#1Beatriz Lozano-Torres (Polytechnic University of Valencia)H-Index: 6
#2Juan F. Blandez (Polytechnic University of Valencia)H-Index: 7
Last. Ramón Martínez-Máñez (Polytechnic University of Valencia)H-Index: 64
view all 9 authors...
: The in vivo optical detection of cellular senescence has been accomplished by using mesoporous silica nanoparticles loaded with the NIR-FDA approved Nile Blue ( NB ) dye and capped with a galactohexasaccharide ( S3 ). Emission at 672 nm of NB is highly quenched inside S3 , yet a remarkable emission enhancement is observed upon cap hydrolysis in the presence of β-galactosidase. The efficacy of the probe to optically detect cellular senescence is tested in vitro in melanoma SK-Mel-103 and breast...
Source